Bone Biologics announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tuesday, June 10 and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, (BBLG) at the market open on June 10.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.